CNL Healthcare Properties: What Happened to the Shares, the NAV History and What Each Share Became
Some links pay us a referral fee; each one says so. Disclosure
Quick Answer
CNL Healthcare Properties, Inc. (CHP, CIK 1496454) no longer exists: Sonida Senior Living (NYSE: SNDA) acquired it on March 10-11, 2026, and its shares were converted into $2.32 in cash plus 0.1318 of a Sonida share each. At the $33.70 Sonida price used in Sonida's accounting, that is about $6.76 per CHP share (our arithmetic), a little below the $6.90 headline and close to the last estimated NAV of $6.64 (December 31, 2024). As of October 6, 2026, CHP's last SEC filing is the Form 15 of March 11, 2026, which reports no holders of record; there are no later CHP filings and nothing further is owed on CHP shares. The history behind that number: CHP sold shares at $10.00, then $10.14 and $10.58, raised $1,666.0 million in subscriptions by the close of its offerings on September 30, 2015, suspended redemptions on July 11, 2018, paid a $2.00 special distribution in May 2019 after selling its medical office buildings to Welltower for $1.25 billion, and cut its quarterly distribution from $0.1164 to $0.0512 to $0.0256 per share. A share bought at $10.00 in 2011 collected about $6.12 in cash distributions through 2025, plus the $6.76 merger package (our arithmetic). Your tax form is the 2026 Form 1099-DIV, due in early 2027.
Key Takeaways
- Status as of October 6, 2026: Sonida Senior Living acquired CHP in two closings on March 10 and 11, 2026; CHP filed a Form 15 on March 11, 2026 and has filed nothing since.
- Per CHP share: $2.32 cash plus 0.1318 SNDA shares, with cash paid in lieu of fractional SNDA shares. At Sonida's booked $33.70 price, about $6.76 (our arithmetic).
- Offering prices: $10.00 (June 2011), $10.14 (December 2013), $10.58 (November 2014 to the close of the offerings on September 30, 2015). Subscriptions raised $1,666.0 million for 162.5 million shares.
- Estimated NAV per share: $9.13 (2013), $9.52 (2014), $9.75, $10.04, $10.32 (2017, the peak), $10.01, then $7.81 after the $2.00 special distribution, $7.38, $7.37, $6.92, $6.28 and $6.64 (December 31, 2024).
- Cash distributions declared per share add up to about $6.12 from 2011 to 2025 (our arithmetic), including the $2.00 special in 2019. From 2022 to 2025 the rate was $0.1024 a year, all of it return of capital.
- Redemptions were suspended from July 11, 2018. The last three tender offers were $3.29 (West 4, January 2025), $3.03 (Comrit, April 2025) and $4.55 (MacKenzie, January 2026).
CSV · 55 rows
CNL Healthcare Properties: offering prices, NAV history, distributions per share, tender offers and the 2026 Sonida merger
55 data points, 2011 to 2026: offering prices, capital raised, every estimated NAV, distributions per share by year, tender offer prices and the merger value, one accession per row.
What CNL Healthcare Properties was
CNL Healthcare Properties, Inc. (SEC CIK 1496454) was a non-traded REIT based in Orlando, Florida, externally managed by an affiliate of CNL Financial Group and sold through brokers by CNL Securities Corp. It started its initial offering on June 27, 2011 and closed its follow-on offering on September 30, 2015. By then it had taken in $1,666.0 million from subscriptions for 162.5 million shares, plus $63.9 million reinvested through its distribution reinvestment plan (FY2015 10-K). The offering price carried a load: selling commissions of up to 7% and a marketing support fee of up to 3% of gross offering proceeds (FY2017 10-K), so not all of each $10 went into property.
At its peak CHP owned seniors housing, medical office buildings, post-acute care and acute care properties. In 2019 it sold 55 medical office buildings and related properties to a Welltower affiliate for a gross price of $1.25 billion, plus a separate sale of inpatient rehabilitation facilities, and kept the seniors housing. At the end of 2024 its portfolio was 70 properties: 69 seniors housing communities and one vacant land parcel (FY2024 10-K). It had 45,719 stockholders of record at the end of 2018.
CHP shares never traded. Its 10-Ks state that “there is currently no established public market for the registrant’s shares of common stock.” A “CHTH” quote page on a financial site is not a market price anyone could have sold at.
Where CNL Healthcare Properties stands now (as of October 6, 2026)
- The company is gone. Sonida's closing 8-K describes two steps: on March 10, 2026 CHP sold equity interests in certain subsidiaries to a Sonida subsidiary, merged with a CHP subsidiary and “adopted a plan of liquidation”; on March 11, 2026 CHP merged into the Sonida subsidiary, “whereupon the separate existence of CHP ceased.”
- The shares are deregistered. CHP filed Form 15 on March 11, 2026, reporting “None” as the approximate number of holders of record. We checked EDGAR on October 6, 2026: there is no CHP filing after that date, so no further NAV, distribution or report will come from CHP.
- Nothing more is owed on CHP shares. The consideration was the cash and the Sonida stock; CHP's FAQ says that once they are distributed, “shareholders will receive a final statement from CHP with a zero balance.” Until closing, the merger agreement allowed CHP to keep paying its regular quarterly dividend of up to $0.0256 a share, pro rated for a partial quarter.
- What you hold now is Sonida. SNDA shares are listed on the NYSE and were issued unrestricted. Sonida is a senior living operator that now owns CHP's communities.
- What is still to come is paperwork: the 2026 Form 1099-DIV and CHP cost-basis information from Computershare, both in early 2027 (see below).
The share price history: offering price and NAV
CHP's price per share was set by its board, first as an offering price and, after the offerings closed, as an estimated NAV. The table shows every value from the 10-Ks and 8-Ks.
| Date | Value per share | What it was | Filing |
|---|---|---|---|
| June 27, 2011 | $10.00 | Initial offering price ($9.50 through the reinvestment plan) | FY2016 10-K |
| September 30, 2013 | $9.13 | Estimated NAV, the basis for the new $10.14 offering price | FY2013 10-K |
| December 11, 2013 | $10.14 | Offering price ($9.64 reinvestment) | FY2016 10-K |
| September 30, 2014 | $9.52 | Estimated NAV | FY2015 10-K |
| November 4, 2014 | $10.58 | Offering price ($10.06 reinvestment) until the offerings closed on September 30, 2015 | FY2016 10-K |
| December 31, 2015 | $9.75 | Estimated NAV (range $9.20 to $10.25) | FY2015 10-K |
| December 31, 2016 | $10.04 | Estimated NAV (range $9.53 to $10.56) | FY2016 10-K |
| December 31, 2017 | $10.32 | Estimated NAV (range $9.79 to $10.81), the peak | FY2017 10-K |
| December 31, 2018 | $10.01 | Estimated NAV | FY2018 10-K |
| December 31, 2019 | $7.81 | Estimated NAV, after the $2.00 special distribution of May 2019 | FY2019 10-K |
| December 31, 2020 | $7.38 | Estimated NAV | FY2021 10-K |
| December 31, 2021 | $7.37 | Estimated NAV | FY2021 10-K |
| December 31, 2022 | $6.92 | Estimated NAV | FY2024 10-K |
| December 31, 2023 | $6.28 | Estimated NAV | FY2024 10-K |
| December 31, 2024 | $6.64 | Estimated NAV (range $6.33 to $6.98), the last one | 8-K, March 2025 |
| November 2025 | $6.90 | Merger headline, subject to certain adjustments | 8-K, February 2026 |
| March 11, 2026 | about $6.76 | Value delivered at closing at SNDA's $33.70 (our arithmetic) | Sonida 10-Q, Q2 2026 |
The drop from $10.01 to $7.81 between 2018 and 2019 was mostly not a loss: $2.00 of it went back to holders in cash as the special distribution. The real erosion came afterwards, from $7.81 at the end of 2019 to $6.28 at the end of 2023.
Distributions per share, year by year
The amounts below are cash distributions declared per share, as printed in each year's statement of stockholders' equity, with the share treated as return of capital for tax purposes from the 10-Ks. Until September 30, 2015 CHP also paid stock distributions of 0.0025 shares per month, which are not in these figures.
| Year | Cash declared per share | Rate and events | Return of capital (tax) |
|---|---|---|---|
| 2011 | $0.06666 | Offering began June 27, 2011; $0.0333 a month | Not in our sources |
| 2012 | $0.39996 | $0.0333 a month | Not in our sources |
| 2013 | $0.39996 | $0.0333 a month | Not in our sources |
| 2014 | $0.4071 | $0.0338 a month, then $0.0353 | 69.2% |
| 2015 | $0.4236 | $0.0353 a month; offerings closed September 30 | 62.2% |
| 2016 | $0.4232 | $0.0353 a month | 62.9% |
| 2017 | $0.4444 | $0.1164 a quarter from Q3 2017 | 100.0% |
| 2018 | $0.46556 | Reinvestment plan and redemptions suspended July 11, 2018 | 100.0% |
| 2019 | $2.26999 | Includes the $2.00 special (May 2019); regular rate cut to $0.0512 a quarter | 37.05% |
| 2020 | $0.20480 | $0.0512 a quarter | 66.35% |
| 2021 | $0.20480 | $0.0512 a quarter | 56.18% |
| 2022 | $0.10240 | Cut to $0.0256 a quarter from Q1 2022 | 100.00% |
| 2023 | $0.10240 | $0.0256 a quarter | 100.00% |
| 2024 | $0.10240 | $0.0256 a quarter | 100.00% |
| 2025 | $0.10240 | $0.0256 a quarter | 100.00% |
| Total 2011-2025 | about $6.12 | Our arithmetic, adding the rows above | - |
The FY2017 10-K prints the 2015 figure as $0.4232 rather than the $0.4236 in the FY2015 10-K; we use the earlier filing. The board declared the special distribution on May 21, 2019 at $2.00 per share, payable on or around May 28, 2019, from the proceeds of the medical office sale.
The return-of-capital column matters for your taxes. A distribution classed as return of capital is not taxed when received but lowers your cost basis, which raises the gain, or shrinks the loss, on the 2026 merger. From 2022 to 2025 every distribution was return of capital.
What one original CHP share became
The merger value per share is the same for everyone. What differs is the price you paid and how many years of distributions you collected. Two cases, using only filed numbers, before taxes and without the stock distributions or reinvestment (our arithmetic):
| $10,000 invested | Bought at $10.00 (2011) | Bought at $10.58 (2015) |
|---|---|---|
| Shares bought | 1,000 | 945.18 |
| Cash distributions counted | 2011-2025: $6.12 a share, $6,120 | 2016-2025: $4.42 a share, $4,180 |
| Merger cash at $2.32 a share | $2,320 | $2,193 |
| Sonida shares at 0.1318 per CHP share | 131.8 shares, $4,442 at $33.70 | 124.57 shares, $4,198 at $33.70 |
| Total received | about $12,881 | about $10,571 |
| Against the $10,000 paid | +28.8% over about 15 years | +5.7% over about 11 years |
A holder in the reinvestment plan bought extra shares at $9.50 to $10.06 until the plan was suspended in 2018, and a 2011-2015 buyer also received the 0.0025-share monthly stock distributions; both add shares, so those totals would be higher than the table. The Sonida part is a moving number: its value is whatever SNDA trades at on the day you sell.
What each CHP share became in the merger
The consideration was fixed in the merger agreement (8-K, November 2025): for each CHP share, $2.32 in cash and SNDA stock worth $4.58, converted at an exchange ratio set within a collar. The agreement specified that if Sonida's closing VWAP “is greater than $34.76, which is 130% of the Signing VWAP, the Exchange Ratio shall be set at 0.1318.” That is where it ended. Sonida's closing 8-K confirms each share received “$2.32 in cash and (ii) 0.1318 of a share of SNDA Common Stock,” and that Sonida “paid approximately $404.4 million in cash and issued an aggregate number of 22,902,649 shares.”
The value of the stock depends on the day you look. Sonida's Q2 2026 10-Q prices the stock consideration at an “SNDA closing stock price” of $33.70, and puts the total preliminary purchase price, including the debt it paid off and the adviser payments, at $1,762,641 thousand. At $33.70:
| Component | Per CHP share | Source |
|---|---|---|
| Cash | $2.32 | Sonida closing 8-K |
| SNDA shares | 0.1318 | Sonida closing 8-K |
| Value of SNDA shares at $33.70 | $4.44 | Sonida Q2 2026 10-Q price; our arithmetic |
| Total at closing | about $6.76 | Our arithmetic |
| Headline aggregate value | $6.90 (subject to certain adjustments) | CHP 8-K, February 2026 |
The gap has a mechanical cause. With a collar, holders are protected if the acquirer's stock falls, up to a point, and capped if it rises. Sonida's stock had run above $34.76, so the ratio stopped at its minimum; the stock then closed at $33.70, below that threshold, and holders absorbed the difference.
Why CHP sold: a debt wall with a date on it
CHP's audited FY2025 financial statements, filed with its March 2026 8-K, explain the timing. All of its borrowings sat in the 2023 credit facilities, which “mature in May 2026. As of the balance sheet date, the Company does not have sufficient cash on hand to satisfy these obligations.” In Sonida's purchase accounting, the “CHP debt settlement payment (inclusive of accrued interest)” was $565,923 thousand.
A seller with its whole balance sheet coming due within months is not negotiating from strength. CHP at least found a buyer; Pacific Oak Strategic Opportunity REIT, facing its own maturities, ended up in a court-approved bond arrangement and stopped filing audited reports.
The vote shows how little attention many holders paid. Of 175,274,045 shares outstanding, 90,380,525 voted for, 1,006,023 against and 2,748,471 abstained (8-K, March 2026). That is 51.6% of all outstanding shares in favor (our arithmetic). Non-traded REITs routinely struggle to get holders to vote at all; we counted six that could not even reach quorum for their 2026 annual meetings.
What the adviser was paid on the way out
CHP was externally managed by an affiliate of CNL Financial Group. Two lines in Sonida's accounting stand out against the proxy statement that holders voted on:
| Item | Proxy estimate (DEFM14A) | Actual (Sonida Q2 2026 10-Q) |
|---|---|---|
| Advisor disposition fee | $8,928 thousand | $14,338 thousand |
| Upfront payments for the advisor assets purchase | $6,076 thousand | $6,076 thousand |
Neither filing we read explains why the disposition fee came in about 61% above the estimate. For scale, CHP's income statement shows asset management fees of $13,846 thousand in 2025, on top of property management fees paid to operators.
The tender offers: what buyers paid while redemptions were shut
With the redemption plan suspended from July 11, 2018 (the company redeemed about $10.9 million of requests received through May 31, 2018 and then stopped), the only exit for seven and a half years was to sell to an outside buyer at a discount. The three most recent offers, with CHP's own comparison:
| Offer | Price per share | What CHP said about it |
|---|---|---|
| West 4 Capital, January 2025 | $3.29 | About 47.6% below the $6.28 NAV at December 31, 2023 |
| Comrit Investments 1, April 2025 | $3.03 | About 54.4% below the $6.64 NAV at December 31, 2024 |
| MacKenzie, January 2026 | $4.55 | 31.5% below the 2024 NAV and 34.1% below the estimated merger consideration |
MacKenzie made its offer with the merger already announced. It later reported: “The merger closed on schedule and we received a total of $1,562,125 in cash and shares which we sold for a profit of $521,718.” Every dollar of that profit came from holders who needed out before the closing. A holder who sold to Comrit at $3.03 in April 2025 gave up about $3.73 a share against the $6.76 that arrived eleven months later (our arithmetic). We track these offers across the category in the non-traded REIT tender offer tracker, and the freezes behind them in the redemption suspension tracker.
Not the same company: CNL Healthcare Properties II
CNL Healthcare Properties II, Inc. (CIK 1648383) was a smaller, separate REIT from the same sponsor. It sold its two remaining senior assisted living properties on February 28, 2020 for about $48.85 million and filed its own Form 15 on March 27, 2020. If your statements say “II”, the Sonida merger terms on this page do not apply to you.
If you held CHP: what to check now
This is general information, not tax or investment advice.
- Your 2026 Form 1099-DIV. CHP's transaction FAQ says “the transaction consideration will be reflected on U.S. stockholders’ 2026 Form 1099-DIV, which will be available in early 2027.” Non-U.S. holders receive Form 1042-S.
- The tax treatment. The proxy says that for U.S. holders the transactions “will be treated as taxable sales” of CHP stock, with gain or loss measured against your adjusted tax basis. The 2019 special distribution and the years of return-of-capital distributions lowered that basis, so a 2011-2015 buyer may have a smaller loss, or a gain, than the $10 cost suggests.
- Your CHP cost basis. The FAQ says “Computershare anticipates having cost-basis information for your CHP shares in early 2027,” and gives the number 866-233-6645. Keep your original purchase records and every year's 1099-DIV.
- Your SNDA shares. They are listed on the NYSE, so unlike CHP they can be sold on any trading day. Shares not held at a broker sit with Computershare in book-entry form; a trust, corporate or plan account may need a brokerage account to sell.
- Any offer to buy “CHP shares” is stale. The shares were converted at closing and the company has deregistered.
If you hold another non-traded REIT that has announced a merger or a listing, the questions are the same ones this deal answers: what the collar does, what the adviser collects, and what the debt schedule forces. We answer them as a Forensic Filing Read, from the proxy and the latest filings, in 72 hours. For how listings and mergers have priced against NAV across the category, see what non-traded REITs fetch when they list.
FAQ
Frequently Asked Questions
Filing alert · free
An email when CNL Healthcare Properties / Sonida files with the SEC
When CNL Healthcare Properties / Sonida files: what changed, the one number that matters, and the accession number to check it yourself.
Sources, read on October 6, 2026: CNL Healthcare Properties' Forms 10-K for 2013 (accession 0001193125-14-118729), 2015 (0001564590-16-014918), 2016 (0001564590-17-004635), 2017 (0001564590-18-006011), 2018 (0001564590-19-008800), 2019 (0001564590-20-013258), 2020 (0001564590-21-013205), 2021 (0000950170-22-004343), 2022 (0001496454-23-000001) and 2024 (0001496454-25-000005); 8-Ks of June 26, 2018 (redemption and reinvestment suspension), May 15 and May 22, 2019 (Welltower sale and special distribution), March 10, 2025 (2024 NAV), November 5, 2025 (merger agreement), January 14, 2026 (MacKenzie letter), February 17, 2026 ($6.90 value and transaction FAQ), March 6, 2026 (vote) and March 9, 2026 (FY2025 audited financial statements); Schedules 14D-9 of February 5 and April 17, 2025 (West 4 and Comrit offers); the definitive proxy statement (DEFM14A, January 6, 2026); Form 15 of March 11, 2026; CNL Healthcare Properties II's 8-K of March 4, 2020 and Form 15 of March 27, 2020; Sonida Senior Living's closing 8-K of March 11, 2026 and Form 10-Q for the quarter ended June 30, 2026 (0001043000-26-000032); and MacKenzie Realty Capital's release on its CHP position. Per-share values of the merger package, totals of distributions, the $10,000 table and percentages not printed in a filing are our arithmetic. This is analysis of public documents, not investment, legal or tax advice.
Keep reading.
- 0123 min read
American Tower Stock (AMT): Dividend vs AFFO, Debt and Tenants
American Tower (NYSE: AMT) declared $1.79 a share in Q2 2026 against $2.71 of AFFO, 66.1% (our arithmetic). Payout on four yardsticks, $5.97 billion of notes due by 2027 at about 2.5%, DISH churn, CoreSite ownership and what to watch before the Q3 10-Q.
- 0226 min read
BN Stock: Earnings by Segment, Dividend and Insurance Leverage, Q2 2026
Brookfield Corporation (NYSE/TSX: BN) earned $0.61 a share before realizations in Q2 2026 and pays $0.28 a year, 11.7% of twelve-month earnings. Segment earnings, what funds the dividend, the insurer's debt and how BN differs from BAM, from its 40-F and 6-Ks.
- 0320 min read
Brookfield Private Equity Fund (BPEF): NAV Up 13.6% in Nine Months While Brookfield's Own Seed Units Are Redeemed
Brookfield Private Equity Fund LP, the evergreen fund Brookfield sells to accredited, qualified-purchaser investors, had a Transactional NAV of $27.96 for Class I on August 31, 2026, up from the $25.00 first price. Its filings show 83% of GAAP net assets are Brookfield's own Class B-1 seed units, redeemed at a discount, with $99 million redeemed in the first half of 2026. A new $200 million secured revolver was signed October 9, 2026. NAV, sales, fees, debt and redemption terms with accession numbers.